Favoritar este trabalho
Como citar esse trabalho?
Resumo

Doxorubicin (DOX) is an antineoplastic drug prescribed for the treatment of cancer in human and veterinary medicine. Despite its wide use, DOX has the potential to cause toxic effects, such as cardiovascular toxicity. Research on cardiotoxicity prevention methods is important to improve survival of cancer patients submitted to the treatment with this drug. Cilostazol (CIL), is a selective phosphodiesterase 3 inhibitor, clinically prescribed to intermittent claudication treatment. Owing to its pleiotropic properties such as anti-inflammatory, antioxidant, and cardioprotective activity, we hypothesize that this drug may exert cardioprotective effects in a murine model of doxorubicin-induced cardiotoxicity

Compartilhe suas ideias ou dúvidas com os autores!

Sabia que o maior estímulo no desenvolvimento científico e cultural é a curiosidade? Deixe seus questionamentos ou sugestões para o autor!

Faça login para interagir

Tem uma dúvida ou sugestão? Compartilhe seu feedback com os autores!

Eixo Temático
  • 17 - Farmacologia Básica e Clínica